Synapse - A phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO-directed bispecific T-cell engager, in patients with advanced solid tumors

A phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO-directed bispecific T-cell engager, in patients with advanced solid tumors Meeting Abstract

Authors:	D'Angelo, S. P.; Subbiah, V.; Blay, J. Y.; Wagner, M. J.; Steeghs, N.; Youk, J.; Mizusako, H.; Ohue, Y.; Jin, J.; Rajper, A. W.; Tesar, N.; Schöffski, P.
Abstract Title:	A phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO-directed bispecific T-cell engager, in patients with advanced solid tumors
Meeting Title:	Journal of Clinical Oncology
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	16_SUPPL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-06-01
Start Page:	TPS2668
End Page:	TPS2668
Language:	English
ACCESSION:	WOS:001534390000001
DOI:	10.1200/JCO.2025.43.16_suppl.TPS2668
PROVIDER:	wos
Notes:	Meeting Abstract -- 16_SUPPL -- TPS2668 -- Source: Wos